메뉴 건너뛰기




Volumn 27, Issue 10, 2008, Pages 757-760

Tools for evidence-based toxicology: Computational-based strategies as a viable modality for decision support in chemical safety evaluation and risk assessment

Author keywords

Causation; Chemical risk assessment; Computational toxicology; Evidence based toxicology; In silico toxicology; Safety evaluation

Indexed keywords

BIOSAFETY; CARCINOGENICITY; CHRONIC TOXICITY; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; MEDICAL INFORMATICS; MEDICAL PRACTICE; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION; TOXICOLOGY;

EID: 57649101402     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327108097689     Document Type: Note
Times cited : (14)

References (19)
  • 2
    • 34250306426 scopus 로고    scopus 로고
    • Toxicological and clinical computational analysis and the US FDA/CDER
    • Benz RD.. Toxicological and clinical computational analysis and the US FDA/CDER. Expert Opin Drug Metab Toxicol 2007 ; 3: 109-124.
    • (2007) Expert Opin Drug Metab Toxicol , vol.3 , pp. 109-124
    • Benz, R.D.1
  • 3
    • 38549117345 scopus 로고    scopus 로고
    • Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach
    • Kapetanovic IM.. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem Biol Interact 2008 ; 30: 165-176.
    • (2008) Chem Biol Interact , vol.30 , pp. 165-176
    • Kapetanovic, I.M.1
  • 4
    • 40949112779 scopus 로고    scopus 로고
    • Understanding genetic toxicity through data mining: The process of building knowledge by integrating multiple genetic toxicity databases
    • Yang C. Hasselgren CH. Boyer S. Arvidson K. Aveston S. Dierkes P.. Understanding genetic toxicity through data mining: the process of building knowledge by integrating multiple genetic toxicity databases. Toxicol Mech Methods 2008 ; 18: 277-295.
    • (2008) Toxicol Mech Methods , vol.18 , pp. 277-295
    • Yang, C.1    Hasselgren, C.H.2    Boyer, S.3    Arvidson, K.4    Aveston, S.5    Dierkes, P.6
  • 5
    • 40949150720 scopus 로고    scopus 로고
    • In silico screening of chemicals for genetic toxicity using MDL-QSAR, nonparametric discriminant analysis, E-State, connectivity, and molecular property descriptors
    • Contrera JF. Matthews E. Kruhlak N. Benz RD.. In silico screening of chemicals for genetic toxicity using MDL-QSAR, nonparametric discriminant analysis, E-State, connectivity, and molecular property descriptors. Toxicol Mech Methods 2008 ; 18: 207-216.
    • (2008) Toxicol Mech Methods , vol.18 , pp. 207-216
    • Contrera, J.F.1    Matthews, E.2    Kruhlak, N.3    Benz, R.D.4
  • 6
    • 40949145715 scopus 로고    scopus 로고
    • Combined use of MC4PC, MDL-QSAR, BioePisteme, Leadscope PDM, and Derek for Windows software to achieve high-performance, high-confidence, mode of action-based predictions of chemical carcinogenesis in rodents
    • Matthews EJ. Kruhlak NL. Benz RD. Contrera JF. Marchant CA. Yang C.. Combined use of MC4PC, MDL-QSAR, BioePisteme, Leadscope PDM, and Derek for Windows software to achieve high-performance, high-confidence, mode of action-based predictions of chemical carcinogenesis in rodents. Toxicol Mech Methods 2008 ; 18: 189-206.
    • (2008) Toxicol Mech Methods , vol.18 , pp. 189-206
    • Matthews, E.J.1    Kruhlak, N.L.2    Benz, R.D.3    Contrera, J.F.4    Marchant, C.A.5    Yang, C.6
  • 7
    • 0032458218 scopus 로고    scopus 로고
    • A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software
    • Matthews EJ. Contrera JF.. A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. Regul Toxicol Pharmacol 1998 ; 28: 242-264.
    • (1998) Regul Toxicol Pharmacol , vol.28 , pp. 242-264
    • Matthews, E.J.1    Contrera, J.F.2
  • 8
    • 8844236997 scopus 로고    scopus 로고
    • Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose
    • Contrera JF. Matthews EJ. Kruhlak NL. Benz RD.. Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. Regul Toxicol Pharmacol 2004 ; 40: 185-206.
    • (2004) Regul Toxicol Pharmacol , vol.40 , pp. 185-206
    • Contrera, J.F.1    Matthews, E.J.2    Kruhlak, N.L.3    Benz, R.D.4
  • 12
    • 34250795654 scopus 로고    scopus 로고
    • Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling
    • Valerio LG. Arvidson KB. Chanderbhan RF. Contrera JF.. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling. Toxicol Appl Pharmacol 2007 ; 222: 1-16.
    • (2007) Toxicol Appl Pharmacol , vol.222 , pp. 1-16
    • Valerio, L.G.1    Arvidson, K.B.2    Chanderbhan, R.F.3    Contrera, J.F.4
  • 13
    • 34250318200 scopus 로고    scopus 로고
    • In silico approaches to explore toxicity end points: Issues and concerns for estimating human health effects
    • Matthews EJ. Contrera JF.. In silico approaches to explore toxicity end points: issues and concerns for estimating human health effects. Expert Opin Drug Metab Toxicol 2007 ; 3: 125-134.
    • (2007) Expert Opin Drug Metab Toxicol , vol.3 , pp. 125-134
    • Matthews, E.J.1    Contrera, J.F.2
  • 14
    • 40949161033 scopus 로고    scopus 로고
    • MultiCASE Expert Systems and the REACH Initiative
    • Saiakhov RD. Klopman G.. MultiCASE Expert Systems and the REACH Initiative. Toxicol Mech Methods 2008 ; 18: 159-175.
    • (2008) Toxicol Mech Methods , vol.18 , pp. 159-175
    • Saiakhov, R.D.1    Klopman, G.2
  • 16
    • 4644235643 scopus 로고    scopus 로고
    • Virtual screening in lead discovery and optimization
    • Jain AN.. Virtual screening in lead discovery and optimization. Curr Opin Drug Discov Devel 2004 ; 7: 396-403.
    • (2004) Curr Opin Drug Discov Devel , vol.7 , pp. 396-403
    • Jain, A.N.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.